Amsterdam Molecular Therapeutics B.V., Digna Biotech, University of Navarra deal

Digna and the university's Center of Applied Medical Research granted AMT exclusive, worldwide rights to develop and commercialize AMT-070 to treat late stage liver cirrhosis. Next year, AMT plans to ...